Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine  

作　　者：Hua Peng Yang-Xin Fu 

机构地区：[1]Institute of Biophysics,Chinese Academy of Sciences,Beijing,China [2]Department of Basic Medical Sciences,School of Medicine,Tsinghua University,Beijing,China

出　　处：《Cell Research》2022年第4期331-332,共2页细胞研究（英文版）

摘　　要：New adjuvants that potently improve vaccine efficacy with extremely low toxicity are urgently needed.In a recent study in Cell Research,Liu et al.show that a new STING agonist CF501 facilitates a SARS-CoV-2 subunit vaccine to elicit robust neutralizing antibody response against several subtypes of sarbecovirus and protects experimental animals from SARS-CoV-2 infection.

关 键 词：VACCINE ADJUVANT al. 

分 类 号：R186[医药卫生—流行病学] R563.1[医药卫生—公共卫生与预防医学]